We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
-0.92%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$313M
AUM Growth
+$43.7M
Cap. Flow
+$70.4M
Cap. Flow %
22.5%
Top 10 Hldgs %
58.61%
Holding
92
New
33
Increased
17
Reduced
11
Closed
31

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$26.8M
2
DXCM icon
DexCom
DXCM
+$24.3M
3
ABBV icon
AbbVie
ABBV
+$21.2M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.1M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$14.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$25.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$21.1M
3
MDT icon
Medtronic
MDT
+$14.2M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$9.82M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.66M

Sector Composition

Rank Sector Weight
1 Healthcare 92.58%
2 Industrials 0.23%
3 Financials 0.16%
4 Technology 0.14%
5 Energy 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXRX icon
51
Recursion Pharmaceuticals
RXRX
$1.68B
$172K 0.06%
+22,471
New +$224K
PSEC icon
52
Prospect Capital
PSEC
$1.11B
$169K 0.05%
+27,957
New +$174K
AM icon
53
Antero Midstream
AM
$10.2B
$161K 0.05%
13,448
+1,773
+15% +$21K
EDIT icon
54
Editas Medicine
EDIT
$448M
$151K 0.05%
19,295
-351,582
-95% -$3.01M
RES icon
55
RPC Inc
RES
$1.31B
$108K 0.03%
+12,071
New +$101K
IRWD icon
56
Ironwood Pharmaceuticals
IRWD
$700M
$99.4K 0.03%
+10,326
New +$101K
UAA icon
57
Under Armour
UAA
$2.83B
$88.4K 0.03%
+12,904
New +$97.1K
SWN
58
DELISTED
Southwestern Energy Company
SWN
$88.3K 0.03%
+13,693
New +$87.3K
GCMG icon
59
GCM Grosvenor
GCMG
$808M
$79.4K 0.03%
+10,229
New +$79.5K
NMRK icon
60
Newmark Group
NMRK
$2.68B
$73.4K 0.02%
+11,417
New +$79.1K
JBLU icon
61
JetBlue
JBLU
$2.36B
$68.8K 0.02%
14,952
+1,061
+8% +$6.98K
ALDX icon
62
Aldeyra Therapeutics
ALDX
$92.9M
– –
-73,067
Closed -$613K
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$30.3B
– –
-29,506
Closed -$5.6M
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.12T
– –
-588
Closed -$201K
CL icon
65
Colgate-Palmolive
CL
$74B
– –
-2,701
Closed -$208K
COGT icon
66
Cogent Biosciences
COGT
$7.11B
– –
-66,885
Closed -$792K
CTAS icon
67
Cintas
CTAS
$80B
– –
-1,656
Closed -$206K
DOV icon
68
Dover
DOV
$28.4B
– –
-1,512
Closed -$223K
KYNB
69
PUT
Kyntra Bio
KYNB
$28.3M
– –
-4,900
Closed -$331K
ILMN icon
70
Illumina
ILMN
$28.4B
– –
-41,975
Closed -$7.66M
JNJ icon
71
Johnson & Johnson
JNJ
$617B
– –
-127,362
Closed -$21.1M
KMI icon
72
Kinder Morgan
KMI
$69.7B
– –
-10,324
Closed -$178K
LEGN icon
73
Legend Biotech
LEGN
$3.74B
– –
-116,768
Closed -$8.06M
LLY icon
74
Eli Lilly
LLY
$1.05T
– –
-54,369
Closed -$25.5M
MDT icon
75
Medtronic
MDT
$110B
– –
-160,660
Closed -$14.2M
1 2
3
4

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Tri Locum Partners held 92 positions worth $313M, up 16% from $269M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Tri Locum Partners deployed $70.4M of net new capital in Q3 2023, opening 33 new positions and adding to 17 existing holdings. Its largest new stake was Amgen: 107,480 shares worth $28.9M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 99% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $7M trimmed.

  • Tri Locum Partners's largest Q3 2023 buy was Amgen: 107,480 shares worth $28.9M.
  • Tri Locum Partners added most to DexCom in Q3 2023, an estimated $24.3M increase.
  • Tri Locum Partners's biggest Q3 2023 reduction was West Pharmaceutical, cutting an estimated $7M.
  • Tri Locum Partners fully exited Eli Lilly in Q3 2023, selling an estimated $25.5M.
  • Tri Locum Partners's ten largest holdings make up 59% of its $313M portfolio in Q3 2023.
  • Tri Locum Partners opened 33 new positions and closed 31 in Q3 2023.
  • Tri Locum Partners's portfolio value rose 16% quarter-over-quarter to $313M.

Based on Tri Locum Partners's 13F filing for Q3 2023, filed 14 Nov 2023.